Browse
Submit Data
Databases
API
Help

Dataset Information

18 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

5-(4-Methyl-phen-yl)-2,3-diphenyl-5,6-dihydro-imidazo[1,2-c]quinazoline.

ABSTRACT: In the title compound, C(29)H(23)N(3), the pyrimidine ring adopts an envelope conformation. The dihedral angle between the phenyl rings attached to the pyrimidine-ring double bond is 62.09?(7)°. In the crystal, mol-ecules are linked by N-H?N hydrogen bonds, forming extended chains in the c-axis direction.

SUBMITTER: Zhang J

PROVIDER: S-EPMC3009266 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

5-(4-Methyl-phen-yl)-2,3-diphenyl-5,6-dihydro-imidazo[1,2-c]quinazoline.

Zhang Jiankang J Qin Xiaofen X Zhou Xingqin X

Acta crystallographica. Section E, Structure reports online 20101009 Pt 11

In the title compound, C(29)H(23)N(3), the pyrimidine ring adopts an envelope conformation. The dihedral angle between the phenyl rings attached to the pyrimidine-ring double bond is 62.09 (7)°. In the crystal, mol-ecules are linked by N-H⋯N hydrogen bonds, forming extended chains in the c-axis direction. ...[more]

PMID: 21588932

Similar Datasets

6-(2-Fluoro-phen-yl)-5,6-dihydro-benzimidazolo[1,2-c]quinazoline.

Project description:In the title compound, C(20)H(14)FN(3), the pyrimidine ring adopts a half-chair conformation. The dihedral angle between the benzimidazole ring system and the fluoro-phenyl ring is 84.18?(10)°. In the crystal structure, mol-ecules are linked into a two-dimensional network parallel to the bc plane by N-H?N and C-H?F hydrogen bonds.

| S-EPMC2959727 | biostudies-literature

2-Methyl-3-(4-methyl-phen-yl)-5,6-diphenyl-2,3-dihydro-pyrazine.

Project description:In the title mol-ecule, C(24)H(22)N(2), four atoms (N-C-C-N) of the heterocyclic ring, with their attached H atoms, and all atoms of the methyl group, are disordered over two positions; the site-occupancy factor of the major component is 0.713?(6). The major disorder component of the heterocyclic ring adopts a half-chair conformation, with all substituents equatorial. The benzene ring adjacent to the methyl group forms dihedral angles of 79.68?(11) and 80.92?(11)° with the phenyl rings; the dihedral angle between adjacent phenyl rings is 59.10 (11)°. The crystal structure features three C-H?? inter-actions.

| S-EPMC3515189 | biostudies-other

2-(2-Chloro-phen-yl)-3-methyl-5,6-diphenyl-2,3-dihydro-pyrazine.

Project description:In the title mol-ecule, C(23)H(19)ClN(2), the heterocyclic ring adopts a screw-boat conformation, with all substituents equatorial. The benzene ring at position 2 makes dihedral angles of 77.88?(12) and 76.31?(12)° with the phenyl rings at positions 5 and 6, respectively. The dihedral angle between the phenyl rings at positions 5 and 6 is 70.05?(10)°. The Cl atom is disordered over two positions with occupancy factors of 0.946?(5) and 0.054?(5). In the crystal, C-H?? inter-actions are found.

| S-EPMC3201404 | biostudies-other

2-Chloro-6,6-dimethyl-5,6-dihydro-indazolo[2,3-c]quinazoline.

Project description:Two independent but virtually identical mol-ecules comprise the asymmetric unit of the title compound, C(16)H(14)ClN(3). The mol-ecules have a slightly curved shape owing to puckering in the six-membered C(4)N(2) ring; the respective dihedral angles formed between the benzene rings are 12.64?(7) and 11.72?(7)°. In the crystal, layers sustained by a combination of N-H?N hydrogen bonding as well as C-H?N and C-H?? contacts are formed; these stack along [011] and are connected by further C-H?? contacts.

| S-EPMC2983602 | biostudies-literature

(2Z)-2-[(2,3-Dimethyl-phen-yl)imino]-1,2-diphenyl-ethanone.

Project description:In the title compound, C(22)H(19)NO, the 2,3-dimethyl-anilinic group is planar with an r.m.s. deviation of 0.0226?Å. The phenyl rings with the carbonyl and imine substituents are also planar with r.m.s. deviations of 0.0019 and 0.0048?Å, respectively. These phenyl rings are oriented at dihedral angles of 74.70?(5) and 79.43?(5)°, respectively, with the 2,3-dimethyl-anilinic group, whereas the dihedral angle between them is 88.28?(4)°. Weak intra-molecular C-H?N hydrogen bonding occurs and completes an S(5) ring motif in the mol-ecule. In the crystal, weak ?-? inter-actions are present between the carbonyl-containing phenyl rings at a centroid-centroid distance of 3.5958?(12)?Å. C-H?? inter-actions between the 2,3-dimethyl-anilinic and the carbonyl-containing phenyl rings are also present, where the C-H group is from the former.

| S-EPMC3007434 | biostudies-literature

2-(5,6-Dihydro-benzimidazo[1,2-c]quinazolin-6-yl)-5-methyl-phenol.

Project description:In the title compound, C(21)H(17)N(3)O, the imidazole ring is essentially planar, with a maximum deviation of 0.009?(1)?Å. The mol-ecule is disordered over two sites corresponding to a rotation of approximately 180° with a refined occupancy ratio of 0.9180?(14):0.0820?(14). The central pyrim-idine ring makes dihedral angles of 5.02?(5), 3.97?(5) and 6.28?(5)°, respectively, with the planes of the imidazole and the terminal phenyl rings for the major component; the values for the minor component are 5.8?(7), 5.0?(6) and 8.5?(6)°, respectively. Part of the observed planarity is accounted for in terms of an intra-molecular N-H?O hydrogen bond. In the crystal, mol-ecules of the major component are connected by O-H?N hydrogen bonds, forming supra-molecular chains along the c axis.

| S-EPMC3200579 | biostudies-literature

6-(2-Chloro-benz-yl)-1-(4-chloro-phen-yl)-7-hy-droxy-2,3-dihydro-1H-imidazo[1,2-a]pyrimidin-5-one.

Project description:The title compound, C(19)H(15)Cl(2)N(3)O(2), was obtained by a one-step cyclo-condensation of 2-amino-1-(4-chloro-phen-yl)imidazoline with diethyl (2-chloro-benz-yl)malonate under basic conditions. In the crystalline state, the mol-ecule exists as the 7-hy-droxy-5-oxo tautomer. The dihedral angles between the fused imidazopyrimidine and aromatic chloro-phenyl and chloro-benzyl rings are 14.2?(1) and 70.7?(1)°, respectively. The conformation of the mol-ecule is influenced by the intra-molecular C-H?O and C-H?N hydrogen bonds, giving a nearly planar five-ring fused system [maximum deviation from the mean plane = 0.296?(2)?Å]. In the crystal structure, strong inter-molecular O-H?O hydrogen bonds link the mol-ecules into chains along the c axis. These chains are further stabilized by weak C-H?Cl and ?-? inter-actions [centroid-centroid distance = 3.6707?(12)?Å].

| S-EPMC3009369 | biostudies-literature

(Z)-3-Chloro-methyl-idene-5,6-dimeth-oxy-2-methyl-2,3-dihydro-1,2-benzothia-zole 1,1-dioxide.

Project description:The title compound, C(11)H(12)ClNO(4)S, adopts a Z configuration about the C=C double bond. The benzisothia-zole system is essentially planar [maximum deviation of 0.235?(2)?Å for the S atom]. In the crystal, the mol-ecules stack parallel to each other in the b-axis direction, with inter-planar spacings for the benzene and thia-zole rings ranging from 3.402?(2) to 3.702?(2)?Å.

| S-EPMC3050289 | biostudies-literature

(Z)-2-[(4-Methyl-phen-yl)sulfon-yl]-1,2-diphenyl-ethene-selenol.

Project description:In the title compound, C(21)H(18)O(2)SSe, the dihedral angle between the cis phenyl rings is 64.3?(1)° and those between the toluene and the phenyl rings are 21.1?(2) and 72.0?(1)°, respectively. An intra-molecular Se-H?O hydrogen bond occurs. In the crystal, mol-ecules are connected by C-H?O hydrogen bonds and weak C-H?? inter-actions help to consolidate the crystal packing.

| S-EPMC3275197 | biostudies-literature

2-Oxo-2,3-dihydro-1H-imidazo[1,2-a]pyridinium iodide.

Project description:In the title compound, C(7)H(7)N(2)O(+)·I(-), the carbonyl C and O atoms of the cation and the iodide ion are situated on mirror planes. The mean plane of the imidazo[1,2-d]pyridinium cation is perpendicular to the mirror plane as a consequence of the disorder of the cation over two opposite orientations of equal occupancy. In the crystal, N-H?I interactions are present.

| S-EPMC2983633 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data